Literature DB >> 18334130

Management of symptoms in amyotrophic lateral sclerosis.

Lisa S Thibodeaux1, Amparo Gutierrez.   

Abstract

The mainstay of treatment of amyotrophic lateral sclerosis (ALS) is management of symptoms. Health care providers involved in the care of ALS patients should be armed with the most current knowledge about symptomatic management of these patients so that an aggressive approach to controlling symptoms can be undertaken at the most appropriate time. Among the important modalities is noninvasive positive pressure ventilation, which has been shown to improve not only quality of life but also survival. Similarly, clinicians should consider earlier intervention with enteral feeding. Palliative care should begin soon after ALS is diagnosed.

Entities:  

Year:  2008        PMID: 18334130     DOI: 10.1007/s11940-008-0009-x

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  55 in total

1.  Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology.

Authors:  W G Bradley; F Anderson; M Bromberg; L Gutmann; Y Harati; M Ross; R G Miller
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

Review 2.  Clinical epidemiology of amyotrophic lateral sclerosis.

Authors:  B R Brooks
Journal:  Neurol Clin       Date:  1996-05       Impact factor: 3.806

3.  Use of enteral glycopyrrolate in the management of drooling.

Authors:  V Lucas; C Amass
Journal:  Palliat Med       Date:  1998-05       Impact factor: 4.762

4.  The control of oral secretions in bulbar ALS/MND.

Authors:  A R Newall; R Orser; M Hunt
Journal:  J Neurol Sci       Date:  1996-08       Impact factor: 3.181

Review 5.  Sleep and neuromuscular disorders.

Authors:  Antonio Culebras
Journal:  Neurol Clin       Date:  2005-11       Impact factor: 3.806

6.  A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients.

Authors:  C E Jackson; J Rosenfeld; D H Moore; W W Bryan; R J Barohn; M Wrench; D Myers; L Heberlin; R King; J Smith; D Gelinas; R G Miller
Journal:  J Neurol Sci       Date:  2001-10-15       Impact factor: 3.181

7.  Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis.

Authors:  Jesús Sancho; Emilio Servera; Juan Díaz; Julio Marín
Journal:  Chest       Date:  2004-04       Impact factor: 9.410

8.  Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS.

Authors:  John Robert Bach
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

9.  Transdermal scopolamine for reduction of drooling in developmentally delayed children.

Authors:  D W Lewis; C Fontana; L K Mehallick; Y Everett
Journal:  Dev Med Child Neurol       Date:  1994-06       Impact factor: 5.449

Review 10.  Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disorders.

Authors:  Amy Cameron; Jeffrey Rosenfeld
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-11       Impact factor: 4.294

View more
  2 in total

1.  Amyotrophic lateral sclerosis: sonographic evaluation of dysphagia.

Authors:  S Tamburrini; A Solazzo; A Sagnelli; L Del Vecchio; A Reginelli; M Monsorrò; R Grassi
Journal:  Radiol Med       Date:  2010-02-19       Impact factor: 3.469

2.  Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management.

Authors:  Emanuela Onesti; Ilenia Schettino; Maria Cristina Gori; Vittorio Frasca; Marco Ceccanti; Chiara Cambieri; Giovanni Ruoppolo; Maurizio Inghilleri
Journal:  Front Neurol       Date:  2017-03-21       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.